Fig. 1: Flow diagram of participants.
Of 512 participants randomized to receive treatment with either adjuvant T-DM1 or TH, 366 were included in the current analytic cohort.
Fig. 1: Flow diagram of participants. | npj Breast Cancer
Of 512 participants randomized to receive treatment with either adjuvant T-DM1 or TH, 366 were included in the current analytic cohort.
